PFIZER
Back to Income Statement
|
PFIZER Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,281 Cr | ₹2,193 Cr | ₹2,425 Cr | ₹2,611 Cr | ₹2,239 Cr |
What is the latest Revenue of PFIZER ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,281 Cr |
| Mar2025 | ₹2,193 Cr |
| Mar2024 | ₹2,425 Cr |
| Mar2023 | ₹2,611 Cr |
| Mar2022 | ₹2,239 Cr |
How is Revenue of PFIZER Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,281 Cr | 4.02 | |
| Mar2025 | ₹2,193 Cr | -9.55 | |
| Mar2024 | ₹2,425 Cr | -7.13 | |
| Mar2023 | ₹2,611 Cr | 16.64 | |
| Mar2022 | ₹2,239 Cr | - | |
Compare Revenue of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹22,399.2 Cr | 1.6% | 8.3% | -6.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 1.6% |
8.3% |
-6.7% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses